For example, we tested independent ALT and AST signals in a genetic interaction model with the PNPLA3 coding variant p.I148M, a well‐established common variant (MAFEUR = 21%) that confers strong susceptibility to NAFLD (Lin et al., 2014). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.